secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2023-07-06T23:59:59+00:00
Accession:  0001193125-23-182808
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD issues 312,525 shares to Rubric Capital for $1.15M; amends bylaws
--------------------------------------------------------------------------------

- Issued 312,525 shares at $3.6797/share to Rubric Capital Management on June 29, 2023, gross proceeds $1,149,998.
- Stockholders approved the Subscription Agreement at the June 26, 2023 annual meeting under Nasdaq rules.
- Board amended bylaws to exempt the Rubric Capital deal from Nevada control share acquisition statutes.
- Shares sold in private placement exempt from registration under Section 4(a)(2) and Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312523182808/0001193125-23-182808-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312523182808/d816117d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-182808

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer